Scott T. Rottinghaus

2022

In 2022, Scott T. Rottinghaus earned a total compensation of $4.4M as Senior Vice President and Chief Medical Officer at Enanta Pharmaceuticals.

Compensation breakdown

Bonus$62,500
Non-Equity Incentive Plan$29,295
Option Awards$2,628,960
Salary$77,557
Stock Awards$1,597,316
Other$337
Total$4,395,965

Rottinghaus received $2.6M in option awards, accounting for 60% of the total pay in 2022.

Rottinghaus also received $62.5K in bonus, $29.3K in non-equity incentive plan, $77.6K in salary, $1.6M in stock awards and $337 in other compensation.

Rankings

In 2022, Scott T. Rottinghaus' compensation ranked 755th out of 5,760 executives tracked by ExecPay. In other words, Rottinghaus earned more than 86.9% of executives.

ClassificationRankingPercentile
All
755
out of 5,760
87th
Division
Manufacturing
337
out of 3,136
89th
Major group
Chemicals And Allied Products
109
out of 1,422
92nd
Industry group
Drugs
96
out of 1,323
93rd
Industry
Pharmaceutical Preparations
71
out of 969
93rd

Pay ratio

Scott T. Rottinghaus' Pay$4,395,965
Median Employee's Pay$249,345
Pay Ratio

18

to 1

In 2022, the annual total compensation of Scott T. Rottinghaus was $4,395,965.

The annual total compensation of the median employee at Enanta Pharmaceuticals was $249,345.

The ratio of Scott T. Rottinghaus' pay to the pay of median employee was therefore 18 to one.

Source: SEC filing on January 20, 2023.

Rottinghaus' colleagues

We found four more compensation records of executives who worked with Scott T. Rottinghaus at Enanta Pharmaceuticals in 2022.

2022

Jay Luly

Enanta Pharmaceuticals

Chief Executive Officer

2022

Yat Or

Enanta Pharmaceuticals

Chief Scientific Officer

2022

Nathaniel Gardiner

Enanta Pharmaceuticals

General Counsel

2022

Paul Mellett

Enanta Pharmaceuticals

Chief Financial Officer

News

In-depth

You may also like